483 Bristol-myers Squibb Company Apr 2008

483 Bristol-myers Squibb Company Apr 2008

Byungja Marciante FDA$119.00 - Available Now

FDA investigators audited the Bristol-myers Squibb Company - New Brunswick, NJ, United States facility and issued inspectional observation (via FDA 483) on 14 Apr 2008.

Product details

  • Category: Human Drugs
  • Inspection end: 14 Apr 2008
  • Location: New Brunswick, United States
  • FEI: 2211101
Add To Cart